Veeva Systems - Cloud-based Software for the Global Life Sciences Industry

Veeva is a leading global provider of industry-specific, cloud-based software solutions for the life sciences industry. Our solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance.

Latest News

September 21, 2017 Industry Survey Reveals Clinical Data Management Delays Are Slowing Trial Completion
83% of life sciences organizations release the clinical database after first patient, first visit, which is associated with downstream delays of up to a month in key data management activities One of the largest, most in-depth surveys of clinical data management professionals shows that the time it takes companies to design and release clinical study databases is having a negative impact on conducting and completing trials. This Smart News Release features multimedia. View the full release here: (Graphic: Business Wire) According to the 2017 eClinical Landscape Study from Tufts Center for the Study of Drug Development , it takes companies an average of 68 days to build and release a clinical study database. Delays in releasing the study database are associated with an increase of nearly a month downstream for other data management processes such as patient data entry and time to lock the database at the end of the study....
August 24, 2017 Veeva Announces Fiscal 2018 Second Quarter Results
Total Revenues of $166.6M, up 27% Year-Over-Year Subscription Services Revenues of $134.3M, up 28% Year-Over-Year Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal second quarter ended July 31, 2017 . “It was another strong quarter for Veeva, with especially good momentum in Vault Clinical,” said CEO Peter Gassner. “We are expanding our market leadership positions and having early success in large new markets. We have all the pieces in place and the disciplined execution needed to achieve our goal of being the most strategic technology partner to the life sciences industry.” Fiscal 2018 Second Quarter Results: Revenues: Total revenues for the second quarter were $166.6 million, up from $131.3 million one year ago, an increase of 27% year-over-year. Subscription services revenues for the second quarter were $134.3 million, up from $105.2 million one year ago, an increase of...
April 25, 2017 Veeva Vault EDC Now Available to Streamline Trial Design and Execution
New cloud application delivers a better EDC to allow
clinical data management teams to run the trial they want Veeva Systems (NYSE: VEEV) today announced the availability of Veeva Vault EDC to help clinical data management teams better run clinical trials. Veeva Vault EDC delivers a flexible, modern cloud application to easily design studies, manage amendments, and improve the speed and quality of data collection. Veeva is bringing together EDC and eSource with CTMS and eTMF to provide the industry’s first and only suite of unified cloud applications to streamline clinical operations and clinical data management. “Veeva Vault EDC allows life sciences companies to run the trial they want, not the trial their technology limits them to,” said Brian Longo , senior vice president and general manager, Veeva Vault EDC. “With a modern cloud EDC, clinical teams can reduce cost and complexity to deliver better data faster and accelerate trial execution.” Traditional EDC systems struggle...

Investor Contact

Rick Lund
Investor Relations Director
Phone: 1 (925) 271-9816

Email Alerts

Email *
Mailing Lists *

Enter the code shown above.